Skip to main content

Natixis

SEC CIK
0001274981
Latest filing
Aug 13, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
267,055
Value
$67.2M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Natixis, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026267,055$67.2M0.3%+33,859+14.5%AddedHolders
Q1 2026233,196$50.7M0.2%−112,180−32.5%ReducedHolders
Q4 2025345,376$78.9M0.3%+122,238+54.8%AddedHolders
Q3 2025223,138$51.7M0.3%−12,502−5.3%ReducedHolders
Q2 2025235,640$43.7M0.2%+3,109+1.3%AddedHolders
Q1 2025232,531$48.2M0.3%+156,918+207.5%AddedHolders
Q4 202475,613$13.4M0.1%−313,257−80.6%ReducedHolders
Q3 2024388,870$76.8M0.5%−255,917−39.7%ReducedHolders
Q2 2024644,787$110.6M0.7%+476,883+284.0%AddedHolders
Q1 2024167,904$30.6M0.2%−209,342−55.5%ReducedHolders
Q4 2023377,246$58.5M0.4%+4,301+1.2%AddedHolders
Q3 2023372,945$55.6M0.4%−124,215−25.0%ReducedHolders
Q2 2023497,160$67.0M0.6%+99,691+25.1%AddedHolders
Q1 2023397,469$63.3M0.6%−203,222−33.8%ReducedHolders
Q4 2022600,691$97.1M0.6%+246,906+69.8%AddedHolders
Q3 2022353,785$47.6M0.2%−21,187−5.7%ReducedHolders
Q2 2022374,972$57.4M0.2%+199,803+114.1%AddedHolders
Q1 2022175,169$28.4M0.1%+43,151+32.7%AddedHolders
Q4 2021132,018$17.7M0.1%−64,874−32.9%ReducedHolders
Q3 2021196,892$21.2M0.1%−463,295−70.2%ReducedHolders
Q2 2021660,187$74.4M0.3%+648,217+5,415.3%AddedHolders
Q1 202111,970$1.29M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.